A high-nucleotide yeast hydrolysate, its preparation method, and its applications

By optimizing the yeast hydrolysis process and employing compound enzyme treatment and heat shock treatment, the nucleotide content in yeast hydrolysate is increased, solving the problem of low nucleotide content in existing technologies and achieving the effect of a highly efficient feed additive.

CN117736889BActive Publication Date: 2026-11-17GUANGDONG HINAPHARM PHARMA CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311770711.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-21
Publication Date
2026-11-17
Estimated Expiration
2043-12-21

AI Technical Summary

Technical Problem

The nucleotide content in existing yeast hydrolysates is low, making it difficult to meet the needs of high-efficiency feed additives.

Method used

By optimizing the yeast hydrolysis process, multiple enzymatic hydrolysis treatments were performed using compound enzymes A and B, combined with heat shock and incubation treatments, to increase the nucleotide content and prepare high-nucleotide yeast hydrolysate.

Benefits of technology

It significantly increased the nucleotide content in yeast hydrolysate, enhancing the immune-boosting and gastrointestinal health maintenance effects of the feed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004621043190000101
    Figure BDA0004621043190000101
  • Figure BDA0004621043190000102
    Figure BDA0004621043190000102
  • Figure BDA0004621043190000111
    Figure BDA0004621043190000111
Patent Text Reader

Abstract

This invention discloses a nucleotide yeast hydrolysate, wherein the high-nucleotide yeast hydrolysate comprises protein, nucleotides, and small peptides. Based on the dry matter mass of the high-nucleotide yeast hydrolysate, the protein content is 45-52%, the nucleotide content is 3-5.5%, and the small peptide content is ≥30%. This application optimizes the yeast hydrolysis process by culturing yeast and then adding compound enzyme A and compound enzyme B to achieve complete enzymatic hydrolysis, resulting in a yeast hydrolysate with a high nucleotide content. When used as a feed additive in feed preparation, the yeast hydrolysate can impart excellent immune-enhancing, gastrointestinal-maintaining, anti-inflammatory, and repair-promoting effects to the feed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial applications, and more specifically, to a high-nucleotide yeast hydrolysate, its preparation method, and its applications. Background Technology

[0002] Yeast hydrolysate, also known as complex yeast, is a pure cultured yeast autolysate obtained by hydrolyzing it using endogenous and exogenous enzymes to release functional components such as nucleic acids and small peptides. High-nucleotide yeast hydrolysate is rich in nucleic acids, nucleotides, small peptides, digestive enzymes, free amino acids, B vitamins, and yeast cell walls. Nucleotides, as the building blocks of nucleic acids, participate in almost all metabolic processes in the body and are important components of many enzymes and coenzymes, playing a crucial role in cellular material and energy metabolism and functional regulation.

[0003] Yeast is a single-celled eukaryotic microorganism and a high-quality protein source. Yeast hydrolysate is a product obtained by liquid fermentation of yeast cells, such as *Candida utilis*, followed by autolysis or exogenous enzyme-catalyzed hydrolysis, and then concentration or drying. Yeast hydrolysate is generally rich in nucleic acids, small peptides, amino acids, glutathione, and other components, and can be used as a source of functional small peptides and exogenous nucleotides, widely applied in young animals. Nucleotides produced through fermentation do not contain any toxic or harmful substances and are suitable as feed additives due to their comprehensive range of nucleic acid types and high product safety. Furthermore, the use of nucleotides as feed additives can improve animals' adaptability and resistance to stress, which is of great significance for maintaining healthy animal production. Nucleotides are also used as palatability enhancers, primarily stimulating the animal's taste buds and possessing a strong umami flavor.

[0004] However, in existing feed yeast hydrolysates, apart from the addition of nucleotides, the content of various nucleotides in the yeast hydrolysates is low after autolysis and enzymatic hydrolysis. For example, after conventional autolysis and enzymatic hydrolysis with a single protease using Saccharomyces cerevisiae, the nucleic acid content is generally 9% to 10%, while the nucleotide content is generally less than 3%. This content still needs to be improved. Therefore, there is a problem of low nucleotide content in yeast hydrolysates in existing technologies. Summary of the Invention

[0005] Therefore, in order to solve the problem of low nucleotide content in yeast hydrolysates in the prior art, this invention provides a high-nucleotide yeast hydrolysate, its preparation method, and its application. The specific technical solution is as follows:

[0006] A high-nucleotide yeast hydrolysate, comprising protein, nucleotides and small peptides, wherein, based on the dry matter mass of the high-nucleotide yeast hydrolysate, the protein content is 45-52%, the nucleotide content is 3-5.5%, and the small peptide content is ≥30%.

[0007] The method for preparing the high nucleotide yeast hydrolysate includes the following steps:

[0008] Yeast milk is prepared by fermenting and culturing yeast strains.

[0009] The yeast milk was subjected to heat shock treatment, and then compound enzyme A was added for one enzymatic hydrolysis treatment to obtain crude yeast hydrolysate.

[0010] Complex enzyme B was added to the crude yeast hydrolysate for a second enzymatic hydrolysis treatment. After incubation, a high-nucleotide yeast hydrolysate was obtained.

[0011] Further, the nucleotides include AMP, UMP, CMP, GMP, and IMP, and by mass percentage: AMP: 1.24–1.54%; UMP: 0.77–0.91%; CMP: 0.85–0.91%; GMP: 1.16–1.2%; IMP: 0.02–0.1%.

[0012] Furthermore, the yeast strain is fermented in a culture medium, which includes a seed culture medium, a primary fermentation culture medium, and a secondary fermentation culture medium.

[0013] Furthermore, the seed culture medium is used to form shake-flask liquid inoculum.

[0014] Furthermore, the primary fermentation medium is used to inoculate the shake flask liquid inoculum and ferment at a temperature of 30℃~32℃, a stirring rate of 200rpm / min~230rpm / min, an aeration rate of 1.0V / V·min~1.2V / V·min, a dissolved oxygen concentration of not less than 40%, a pH of 4.2~6.0, and a fermentation time of 12h~15h to prepare a seed liquid.

[0015] Furthermore, the secondary fermentation medium is used to inoculate the seed liquid, and the fermentation temperature is 30℃~32℃, the stirring rate is 180rpm / min~200rpm / min, the aeration rate is 1.0V / V·min~1.2V / V·min, the dissolved oxygen concentration is not less than 40%, the pH is 4.2~6.0, and the fermentation time is 8h~12h.

[0016] Furthermore, the temperature of the heat shock treatment is 85℃~98℃, and the time is 65s~125s.

[0017] Furthermore, the complex enzyme A consists of papain, trypsin, and β-glucanase in a mass ratio of (1-5):(1-4):(1-2).

[0018] Furthermore, based on the mass of the yeast milk dry matter, the amount of the added complex enzyme A accounts for 0.1% to 0.5% of the yeast milk dry matter.

[0019] Furthermore, the temperature of the first enzymatic hydrolysis treatment is 40℃~50℃, and the time is 8h~10h.

[0020] The above scheme optimizes the yeast hydrolysis process. After culturing the yeast, compound enzymes A and B are added to fully hydrolyze the yeast, resulting in a yeast hydrolysate with high nucleotide content. The overall protein content is 45-52%, the nucleotide content is 3-5.5%, and the small peptide content is ≥30%. When the yeast hydrolysate is used as a feed additive in feed preparation, it can give the feed excellent effects of enhancing immunity, maintaining gastrointestinal health, anti-inflammation, and promoting body repair. Detailed Implementation

[0021] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to its embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and do not limit the scope of protection of the invention.

[0022] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. The terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0023] It should be noted that AMP represents adenine monophosphate, UMP represents uracil monophosphate, CMP represents cytosine monophosphate, GMP represents guanine monophosphate, and IMP represents inosine monophosphate.

[0024] An embodiment of the present invention provides a high-nucleotide yeast hydrolysate, wherein the high-nucleotide yeast hydrolysate comprises protein, nucleotides, and small peptides, and the protein content is 45-52%, the nucleotide content is 3-5.5%, and the small peptide content is ≥30% based on the dry matter mass of the high-nucleotide yeast hydrolysate.

[0025] The method for preparing the high nucleotide yeast hydrolysate includes the following steps:

[0026] Yeast milk is prepared by fermenting and culturing yeast strains.

[0027] The yeast milk was subjected to heat shock treatment, and then compound enzyme A was added for one enzymatic hydrolysis treatment to obtain crude yeast hydrolysate.

[0028] Complex enzyme B was added to the crude yeast hydrolysate for a second enzymatic hydrolysis treatment. After incubation, a high-nucleotide yeast hydrolysate was obtained.

[0029] In one embodiment, the nucleotides include AMP, UMP, CMP, GMP, and IMP, and by mass percentage, AMP: 1.24–1.54%; UMP: 0.77–0.91%; CMP: 0.85–0.91%; GMP: 1.16–1.2%; and IMP: 0.02–0.1%.

[0030] In one embodiment, the yeast strain is fermented in a culture medium, which includes a seed culture medium, a primary fermentation culture medium, and a secondary fermentation culture medium.

[0031] In one embodiment, the seed culture medium is used to form a shake flask liquid inoculum.

[0032] In one embodiment, the primary fermentation medium is used to inoculate the shake flask liquid inoculum, and the seed culture is prepared by fermentation at a temperature of 30℃~32℃, a stirring rate of 200rpm / min~230rpm / min, an aeration rate of 1.0V / V·min~1.2V / V·min, a dissolved oxygen concentration of not less than 40%, a pH of 4.2~6.0, and a fermentation time of 12h~15h.

[0033] In one embodiment, the seed culture is obtained by culturing in a fermentation medium, isolating single colonies, and obtaining yeast with enhanced antioxidant capacity.

[0034] In one embodiment, the yeast strain is directly derived from the yeast in the applicant's prior patent, with a deposit date of April 29, 2020; the depository is Guangdong Provincial Microbial Culture Collection Center (GDMCC), located at 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou; the deposit number is GDMCC No. 70011; and the deposit method is vacuum freeze-dried tube.

[0035] In one embodiment, the secondary fermentation medium is used to inoculate the seed liquid, and the fermentation temperature is 30℃~32℃, the stirring rate is 180rpm / min~200rpm / min, the aeration rate is 1.0V / V·min~1.2V / V·min, the dissolved oxygen concentration is not less than 40%, the pH is 4.2~6.0, and the fermentation time is 8h~12h.

[0036] In one embodiment, the temperature of the heat shock treatment is 85°C to 98°C, and the time is 65s to 125s.

[0037] In one embodiment, the complex enzyme A consists of papain, trypsin, and β-glucanase in a mass ratio of (1-5):(1-4):(1-2).

[0038] In one embodiment, the amount of the complex enzyme A added is 0.1% to 0.5% of the dry yeast milk, based on the mass of the yeast milk.

[0039] In one embodiment, the temperature of the first enzymatic hydrolysis treatment is 40°C to 50°C, and the time is 8h to 10h.

[0040] In one embodiment, the complex enzyme B comprises a nuclease and a rennet in a mass ratio of (1-5):(1-3).

[0041] In one embodiment, the amount of compound enzyme B added is 0.1% to 0.5% of the dry matter of crude yeast hydrolysate, based on the mass of the crude yeast hydrolysate.

[0042] In one embodiment, the secondary enzymatic hydrolysis treatment is carried out at a temperature of 35°C to 60°C for 3 hours to 5 hours.

[0043] In one embodiment, after the secondary enzymatic hydrolysis, an enzyme inactivation treatment is required, in which the temperature is raised to 98°C and the enzyme inactivation treatment is carried out for 20 to 30 minutes.

[0044] In one embodiment, the mechanical treatment is a stirring process performed by an agitator at a stirring speed of 250 r / min to 500 r / min.

[0045] In one embodiment, the temperature of the heat preservation treatment is 45°C to 50°C, and the time is 20 min to 30 min.

[0046] In one embodiment, after the heat preservation treatment, the product is concentrated to a mass concentration of 30% at 45°C to 50°C, and then spray-dried at 100°C under a negative pressure of 200Pa to 500Pa.

[0047] In one embodiment, the high-nucleotide yeast hydrolysate is added as a feed additive to the feed preparation field, preferably to pig feed.

[0048] In one embodiment, when the high-nucleotide yeast hydrolysate is used as a feed additive, the amount added is 1% to 20% of the basal diet mass, preferably 3% to 7%.

[0049] The above scheme optimizes the yeast hydrolysis process. After culturing the yeast, compound enzymes A and B are added to fully hydrolyze the yeast. After heat preservation treatment, a yeast hydrolysate with high nucleotide content is obtained. At the same time, the yeast hydrolysate is used as a feed additive in feed preparation, which can give the feed excellent effects of enhancing the body's immunity, maintaining the body's gastrointestinal tract, anti-inflammation, and promoting body repair.

[0050] The implementation schemes of the present invention will now be described in detail with reference to specific embodiments.

[0051] Example 1:

[0052] A method for preparing a high-nucleotide yeast hydrolysate includes the following steps:

[0053] A yeast strain was fermented and cultured in a culture medium comprising a seed culture medium, a primary fermentation medium, and a secondary fermentation medium. A liquid inoculum was inoculated into a shake flask using the seed culture medium, and then the liquid inoculum was used to inoculate the shake flask in the primary fermentation medium. The fermentation was carried out at 32°C, with a stirring rate of 230 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 12 h to prepare a seed culture. The seed culture was then inoculated into the secondary fermentation medium, and the fermentation was carried out at 30°C, with a stirring rate of 180 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 8 h to prepare a yeast emulsion.

[0054] Yeast milk was heat-shocked at 95℃ for 125s, and then compound enzyme A was added for a first enzymatic hydrolysis treatment at 40℃ for 8h to obtain crude yeast hydrolysate.

[0055] Complex enzyme B was added to the crude yeast hydrolysate for a second enzymatic hydrolysis at 45°C for 3 hours. The temperature was then raised to 98°C for 20 minutes to inactivate the enzyme, and the mixture was stirred at 250 r / min. The mixture was then kept at 45°C for 20 minutes and concentrated to a mass concentration of 30% at 45°C. Finally, the mixture was spray-dried at 100°C under a negative pressure of 200 Pa to obtain a high-nucleotide yeast hydrolysate.

[0056] Example 2:

[0057] A method for preparing a high-nucleotide yeast hydrolysate includes the following steps:

[0058] A yeast strain was fermented and cultured in a culture medium comprising a seed culture medium, a primary fermentation medium, and a secondary fermentation medium. A liquid inoculum was inoculated into a shake flask using the seed culture medium, and then the liquid inoculum was used to inoculate the shake flask in the primary fermentation medium. The fermentation was carried out at 32°C, with a stirring rate of 230 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 12 h to prepare a seed culture. The seed culture was then inoculated into the secondary fermentation medium, and the fermentation was carried out at 30°C, with a stirring rate of 180 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 8 h to prepare a yeast emulsion.

[0059] Yeast milk was heat-shocked at 85℃ for 125 seconds, and then compound enzyme A was added for a first enzymatic hydrolysis treatment at 50℃ for 8 hours to obtain crude yeast hydrolysate.

[0060] Complex enzyme B was added to the crude yeast hydrolysate for a second enzymatic hydrolysis at 50°C for 4 minutes. The temperature was then raised to 98°C for enzyme inactivation for 25 minutes, and the mixture was stirred at 300 r / min. The mixture was then kept at 45°C for 20 minutes and concentrated to a mass concentration of 30% at 45°C. Finally, the mixture was spray-dried at 100°C under a negative pressure of 250 Pa to obtain a high nucleotide yeast hydrolysate.

[0061] Example 3:

[0062] A method for preparing a high-nucleotide yeast hydrolysate includes the following steps:

[0063] A yeast strain was fermented and cultured in a culture medium comprising a seed culture medium, a primary fermentation medium, and a secondary fermentation medium. A liquid inoculum was inoculated into a shake flask using the seed culture medium, and then the liquid inoculum was used to inoculate the shake flask in the primary fermentation medium. The fermentation was carried out at 32°C, with a stirring rate of 230 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 14 h to prepare a seed culture. The seed culture was then inoculated into the secondary fermentation medium, and the fermentation was carried out at 31°C, with a stirring rate of 200 rpm / min, an aeration rate of 1.2 V / V·min, a dissolved oxygen concentration of 5%, a pH of 6.0, and a fermentation time of 10 h to prepare a yeast emulsion.

[0064] Yeast milk was heat-shocked at 95℃ for 125s, and then compound enzyme A was added for a first enzymatic hydrolysis treatment at 45℃ for 10h to obtain crude yeast hydrolysate.

[0065] Complex enzyme B was added to the crude yeast hydrolysate for a second enzymatic hydrolysis at 50°C for 5 hours. The temperature was then raised to 98°C for enzyme inactivation for 25 minutes, and the mixture was stirred at 320 r / min. The mixture was then kept at 48°C for 25 minutes and concentrated to a mass concentration of 30% at 50°C. Finally, it was spray-dried at 100°C under a negative pressure of 250 Pa to obtain a high-nucleotide yeast hydrolysate.

[0066] It should be noted that in Examples 1 to 3, the amount of compound enzyme A added accounts for 5% of the dry matter of yeast milk based on the mass of yeast milk; and the amount of compound enzyme B added accounts for 5% of the dry matter of crude yeast hydrolysate based on the mass of crude yeast hydrolysate.

[0067] Comparative Examples 1-3:

[0068] The difference between Comparative Examples 1-3 and Example 3 is that the composition and amount of compound enzyme A are different, while the rest are the same as Example 3.

[0069] Comparative Examples 4-5:

[0070] The difference between Comparative Examples 4 and 5 and Example 3 is that the composition and amount of compound enzyme B are different, while the rest are the same as Example 3.

[0071] Comparative Example 6:

[0072] The difference between Comparative Example 6 and Example 3 is that Comparative Example 6 did not include treatment with compound enzyme A, while the rest was the same as Example 3.

[0073] Comparative Example 7:

[0074] The difference between Comparative Example 7 and Example 3 is that Comparative Example 7 did not include treatment with compound enzyme B, while the rest was the same as Example 3.

[0075] Comparative Example 8:

[0076] The difference between Comparative Example 8 and Example 3 is that Comparative Example 8 did not undergo heat preservation treatment, but otherwise it was the same as Example 3.

[0077] Comparative Example 9:

[0078] The difference between Comparative Example 9 and Example 3 is that Comparative Example 9 uses a single papain for treatment, and the specific steps are as follows:

[0079] A method for preparing a nucleotide yeast hydrolysate includes the following steps:

[0080] A yeast strain was fermented and cultured in a culture medium comprising a seed culture medium, a primary fermentation medium, and a secondary fermentation medium. A liquid inoculum was inoculated into a shake flask using the seed culture medium, and then the liquid inoculum was used to inoculate the shake flask in the primary fermentation medium. The fermentation was carried out at 32°C, with a stirring rate of 230 rpm / min, an aeration rate of 1.0 V / V·min, a dissolved oxygen concentration of 50%, a pH of 6.0, and a fermentation time of 14 h to prepare a seed culture. The seed culture was then inoculated into the secondary fermentation medium, and the fermentation was carried out at 31°C, with a stirring rate of 200 rpm / min, an aeration rate of 1.2 V / V·min, a dissolved oxygen concentration of 5%, a pH of 6.0, and a fermentation time of 10 h to prepare a yeast emulsion.

[0081] Yeast milk was heat-shocked at 95℃ for 125s, then papain was added for enzymatic hydrolysis at 48℃ for 11h. Finally, it was spray-dried at 100℃ under a negative pressure of 250Pa to obtain nucleotide yeast hydrolysate.

[0082] The components and amounts of complex enzyme A and complex enzyme B in Examples 1-3 and Comparative Examples 1-5 are shown in Table 1 below.

[0083] Table 1: Mass Ratio

[0084]

[0085] The components of the high-nucleotide yeast hydrolysates obtained in Examples 1-3 and Comparative Examples 1-8 were analyzed. Protein content was determined according to GB / T6432-94, the method for determining protein in feed. The specific procedure was as follows: 1g of sample was taken and digested with 12ml of concentrated sulfuric acid in the presence of a mixed catalyst (0.4g copper sulfate pentahydrate + 6g potassium sulfate); then distilled, and the ammonia in the product was absorbed with boric acid; finally, it was titrated with 0.1mol / L hydrochloric acid, and the data were read. The nitrogen content was calculated, and the protein coefficient was N (nitrogen content) × 6.25. The protein content was calculated, and the results showed that the protein content in Examples 1-3 was 45-52%, and the small peptide content was ≥30%.

[0086] Nucleotide determination was performed according to GB / T23530-2009. The results are shown in Table 2 below.

[0087] Table 2: %

[0088]

[0089]

[0090] As can be seen from Table 2, the combination of enzymes with different components in this application can help to obtain higher nucleotide content, and combined with the process, it has a positive effect on the obtained high nucleotide yeast hydrolysate.

[0091] In addition, several animal experiments were conducted to investigate the effects on serum biochemical parameters of piglets. Sixty weaned piglets, approximately 20 days old and weighing 6.00 kg, in good condition, were selected. The basal diet and nutritional composition of the weaned piglets are shown in Table 3 below. They were divided into three experimental groups (applicable to both males and females), corresponding to Application Example 1, Application Example 2, and Application Example 3, with 20 piglets in each group. The experiment lasted for 14 days.

[0092] The results are shown in Table 4. Application Example 1:

[0093] The high nucleotide yeast hydrolysate prepared in Example 3 was added to pig feed as a feed additive at a rate of 4% of the basal diet weight.

[0094] Application Example 2:

[0095] The high nucleotide yeast hydrolysate prepared in Example 3 was added to pig feed as a feed additive at a rate of 5% of the basal diet weight.

[0096] Application Example 3:

[0097] The high nucleotide yeast hydrolysate prepared in Example 3 was added to pig feed as a feed additive at a rate of 7% of the basal diet weight.

[0098] Table 3: Basic Diet and Nutritional Composition for Weaned Piglets

[0099]

[0100]

[0101] It should be noted that the premix provides the following per kilogram of feed: VA 11000 IU, VD3 1100 IU, VE 30 IU, VK 2.5 mg, VB 12 100μg, VB1 3mg, VB2 10mg, niacin 150mg, D-pantothenic acid 60mg, folic acid 1.5mg, VB6 8mg, biotin 0.4mg, iron (FeSO4·H2O) 120mg, copper (CuSO4·H2O) 6mg, manganese (MnSO4·H2O) 4mg, zinc (ZnSO4·H2O) 100mg, iodine (CaI2O6) 0.14mg, selenium (Na2SeO3) 0.3mg.

[0102] Table 4:

[0103]

[0104] The data analysis in Table 4 shows that the high nucleotide yeast hydrolysate of this application has a significant effect on maintaining the body's immunity.

[0105] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0106] The embodiments described above are merely illustrative of several implementations of the present invention, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the invention patent. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these all fall within the protection scope of the present invention. Therefore, the protection scope of this invention patent should be determined by the appended claims.

Claims

1. A high nucleotide yeast hydrolysate comprising proteins, nucleotides and small peptides, characterized in that, Based on the dry matter weight of the high-nucleotide yeast hydrolysate, the protein content is 45-52%, the nucleotide content is 3-5.5%, and the small peptide content is ≥30%; the nucleotides include AMP, UMP, CMP, GMP, and IMP, and by mass percentage, AMP: 1.24-1.54%; UMP: 0.77-0.91%; CMP: 0.85–0.91%; GMP :1.16~1.2%; IMP: 0.02–0.1%; The method for preparing the high nucleotide yeast hydrolysate includes the following steps: Yeast milk is prepared by fermenting and culturing yeast strains. Yeast milk is subjected to heat shock treatment at a temperature of 85℃~98℃ for 65s~125s, followed by the addition of compound enzyme A for a first enzymatic hydrolysis treatment at a temperature of 40℃~50℃ for 8h~10h. The compound enzyme A is composed of papain, trypsin and β-glucanase in a mass ratio of (1~5):(1~4):(1~2) to obtain crude yeast hydrolysate. A compound enzyme B is added to the crude yeast hydrolysate for a second enzymatic hydrolysis at 35-60°C for 3-5 hours. The compound enzyme B consists of nuclease and rennet in a mass ratio of (1-5):(1-3). The amount of compound enzyme B added is 0.1%-0.5% of the dry matter of the crude yeast hydrolysate. After incubation, a high-nucleotide yeast hydrolysate is obtained.

2. The high nucleotide yeast hydrolysate according to claim 1, characterized in that, The yeast strain is fermented in a culture medium, which includes a seed culture medium, a primary fermentation culture medium, and a secondary fermentation culture medium.

3. The high nucleotide yeast hydrolysate according to claim 2, characterized in that, The seed culture medium is used to form liquid inoculum in shake flasks.

4. The high-nucleotide yeast hydrolysate according to claim 3, characterized in that, The primary fermentation medium is used to inoculate the shake flask liquid inoculum, and the fermentation temperature is 30℃~32℃, the stirring rate is 200 rpm / min~230 rpm / min, the aeration rate is 1.0 V / V·min~1.2 V / V·min, the dissolved oxygen concentration is not less than 40%, the pH is 4.2~6.0, and the fermentation time is 12h~15h to prepare a seed liquid.

5. The high-nucleotide yeast hydrolysate according to claim 4, characterized in that, The secondary fermentation medium is used to inoculate the seed liquid, and the fermentation temperature is 30℃~32℃, the stirring rate is 180 rpm / min~200 rpm / min, the aeration rate is 1.0 V / V·min~1.2 V / V·min, the dissolved oxygen concentration is not less than 40%, the pH is 4.2~6.0, and the fermentation time is 8h~12h.

6. The high nucleotide yeast hydrolysate according to claim 1, characterized in that, The amount of the compound enzyme A added accounts for 0.1% to 0.5% of the dry matter of yeast milk, based on the mass of the yeast milk.

Citation Information

Patent Citations

  • High-protein nucleotide type yeast hydrolysate for feed, and preparation method and application of high-protein nucleotide type yeast hydrolysate

    CN111513180A

  • Method for the preparation of a yeast extract, said yeast extract, its use as a food flavour, and a food composiiton comprising the yeast extract

    US5288509A